The Effects of Switching from Dipeptidyl Peptidase-4 Inhibitors to Glucagon-Like Peptide-1 Receptor Agonists on Bone Mineral Density in Diabetic Patients.

Huang, Chun-Feng; Mao, Tso-Yen; Hwang, Shinn-Jang

Huang, Chun-Feng; Mao, Tso-Yen; Hwang, Shinn-Jang.

Afiliación

Huang CF; Division of Family Medicine, En Chu Kong Hospital, New Taipei City, Taiwan, Republic of China.
Mao TY; Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China.
Hwang SJ; Department of Leisure Services Management, Chaoyang University of Technology, Taichung, Taiwan, Republic of China.

Diabetes Metab Syndr Obes ; 16: 31-36, 2023.

Article en En | MEDLINE | ID: mdl-36760582

Palabras clave

bone mineral density; diabetes; dipeptidyl peptidase-4 inhibitor; glucagon-like peptide-1 receptor agonist; osteoporosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Diabetes Metab Syndr Obes Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google